Ukraine’s Security Service confirms Russian MP’s assassin had military backgroundWorld March 24, 14:17
Russian Aerospace Force to receive 200 medium-range aircraft missiles in 2017Military & Defense March 24, 14:14
Russia makes major breakthrough in reducing tuberculosis deaths — ministerSociety & Culture March 24, 14:04
Russia’s Central Bank reduces key rate to 9.75%Business & Economy March 24, 13:39
PM Medvedev says Russia will continue focusing on reasonable import substitutionBusiness & Economy March 24, 13:26
France 'ceased to be a fully sovereign nation' — Le PenWorld March 24, 13:21
Press review: Kiev’s cynical use of Russian MP's murder and Moscow skips ‘nuke ban’ talksPress Review March 24, 13:00
Commander says National Guard prevented numerous civilian deaths in ChechnyaRussian Politics & Diplomacy March 24, 12:58
Kiev reveals identity of Russian politician’s killerWorld March 24, 12:19
MOSCOW, October 11. /TASS/. Russian tennis star Maria Sharapova can participate in exhibition matches as it does not violate the terms of her current suspension, the International Tennis Federation (ITF) told TASS.
Sharapova, who is currently under suspension over anti-doping rules violations, participated recently in the exhibition matches at the tennis tournament in Las Vegas.
"Exhibition events are not covered events under the Tennis Anti-Doping Program so Sharapova is able to participate," the ITF said in its statement addressed to TASS.
Sharapova has been serving a two-year suspension for the violation of anti-doping regulations since January 26. However, the Swiss-based Court of Arbitration for Sport (CAS) ruled October 4 to reduce her suspension term from 24 to 15 months.
The Russian player is now eligible to officially return back to tennis courts starting April 26 next year.
In early March, Sharapova was first to announce that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
On June 9, Sharapova filed an appeal with the CAS in Switzerland’s Lausanne against her two-year suspension, which was officially announced on June 8 by the International Tennis Federation (ITF) Tribunal over anti-doping violations.
Due to the imposed ban Sharapova, the silver Olympic medalist of the 2012 Games in London, had to miss the 2016 Summer Olympic Games, held in August in Brazil’s Rio de Janeiro.
Mildronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without a doctor’s prescription.